David E. Elder

23.3k total citations · 6 hit papers
215 papers, 14.8k citations indexed

About

David E. Elder is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, David E. Elder has authored 215 papers receiving a total of 14.8k indexed citations (citations by other indexed papers that have themselves been cited), including 147 papers in Oncology, 74 papers in Molecular Biology and 37 papers in Immunology. Recurrent topics in David E. Elder's work include Cutaneous Melanoma Detection and Management (128 papers), Melanoma and MAPK Pathways (34 papers) and Immunotherapy and Immune Responses (30 papers). David E. Elder is often cited by papers focused on Cutaneous Melanoma Detection and Management (128 papers), Melanoma and MAPK Pathways (34 papers) and Immunotherapy and Immune Responses (30 papers). David E. Elder collaborates with scholars based in United States, France and Australia. David E. Elder's co-authors include Meenhard Herlyn, DuPont Guerry, Wallace H. Clark, Allan C. Halpern, DuPont Guerry, Mark H. Greene, Xiaowei Xu, Marie Synnestvedt, Patricia Van Belle and Rosalie Elenitsas and has published in prestigious journals such as Science, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

David E. Elder

210 papers receiving 14.3k citations

Hit Papers

A Tumorigenic Subpopulation with Stem Cell ... 1984 2026 1998 2012 2005 1989 1984 1990 1999 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. A Tumorigenic Subpopulation with Stem Cell Properties in Melanomas
    2005 1.0k citations Xiaowei Xu, David E. Elder et al. profile →
  2. Model Predicting Survival in Stage I Melanoma Based on Tumor Progression
    1989 940 citations W. H. Clark, David E. Elder et al. profile →
  3. A study of tumor progression: The precursor lesions of superficial spreading and nodular melanoma
    1984 716 citations David E. Elder et al. profile →
  4. Integrin distribution in malignant melanoma: association of the beta 3 subunit with tumor progression.
    1990 667 citations David E. Elder, Meenhard Herlyn et al. PubMed profile →
  5. Lever's Histopathology of the Skin
    1999 626 citations David E. Elder profile →
  6. Guidelines of care for the management of primary cutaneous melanoma
    2018 393 citations David E. Elder et al. Journal of the American Academy of Dermatology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David E. Elder United States 62 9.0k 6.2k 2.6k 2.6k 2.5k 215 14.8k
Boris C. Bastian United States 70 12.0k 1.3× 12.6k 2.0× 1.6k 0.6× 3.4k 1.3× 3.0k 1.2× 201 20.8k
Víctor G. Prieto United States 65 8.8k 1.0× 4.8k 0.8× 4.0k 1.5× 2.1k 0.8× 916 0.4× 556 16.0k
Timothy M. Johnson United States 62 9.6k 1.1× 4.1k 0.6× 3.1k 1.2× 1.3k 0.5× 965 0.4× 227 14.9k
Hensin Tsao United States 50 5.5k 0.6× 5.1k 0.8× 1.4k 0.5× 1.7k 0.7× 1.3k 0.5× 191 9.6k
Wallace H. Clark United States 48 6.4k 0.7× 2.9k 0.5× 1.9k 0.7× 1.3k 0.5× 1.3k 0.5× 110 9.0k
Alan N. Houghton United States 72 7.7k 0.9× 7.2k 1.2× 671 0.3× 8.9k 3.4× 1.4k 0.6× 208 16.8k
Allan Balmain United States 64 7.8k 0.9× 12.5k 2.0× 635 0.2× 1.3k 0.5× 2.1k 0.8× 204 18.4k
Kevin C. Gatter United Kingdom 88 8.2k 0.9× 12.7k 2.0× 1.1k 0.4× 3.6k 1.4× 1.2k 0.5× 311 26.8k
Carola Berking Germany 50 5.5k 0.6× 4.0k 0.6× 1.8k 0.7× 1.8k 0.7× 757 0.3× 319 10.5k
Robert L. Yauch United States 40 3.2k 0.4× 6.9k 1.1× 1.0k 0.4× 1.1k 0.4× 567 0.2× 70 10.2k

Countries citing papers authored by David E. Elder

Since Specialization
Citations

This map shows the geographic impact of David E. Elder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David E. Elder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David E. Elder more than expected).

Fields of papers citing papers by David E. Elder

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David E. Elder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David E. Elder. The network helps show where David E. Elder may publish in the future.

Co-authorship network of co-authors of David E. Elder

This figure shows the co-authorship network connecting the top 25 collaborators of David E. Elder. A scholar is included among the top collaborators of David E. Elder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David E. Elder. David E. Elder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Barnhill, Raymond L., Michael W. Piepkorn, Lyn M. Duncan, et al.. (2024). MPATH-Dx version 2.0 schema for melanocytic lesions: A robust tool for standardized diagnostic reporting. Clinics in Dermatology. 43(3). 306–314. 2 indexed citations
2.
Elder, David E. & Walter F. Lever. (2021). Atlas of dermatopathology : synopsis and atlas of Lever's histopathology of the skin. 1 indexed citations
3.
Straker, Richard J., Nicholas M. Kelly, Adrienne B. Shannon, et al.. (2021). Local recurrence in patients undergoing wide excision and sentinel lymph node biopsy for cutaneous malignant melanoma: A single-center, retrospective cohort analysis. Journal of the American Academy of Dermatology. 87(1). 247–250. 1 indexed citations
4.
Piepkorn, Michael W., Gary Longton, Lisa M. Reisch, et al.. (2019). Assessment of Second-Opinion Strategies for Diagnoses of Cutaneous Melanocytic Lesions. JAMA Network Open. 2(10). e1912597–e1912597. 32 indexed citations
5.
Parekh, Vishwas, Joseph F. Sobanko, Christopher J. Miller, et al.. (2018). NRAS Q61R and BRAF G466A mutations in atypical melanocytic lesions newly arising in advanced melanoma patients treated with vemurafenib. Journal of Cutaneous Pathology. 46(3). 190–194. 4 indexed citations
6.
Sinnamon, Andrew J., Yun Song, Madalyn G. Neuwirth, et al.. (2018). The prognostic significance of tumor-infiltrating lymphocytes for primary melanoma varies by sex. Journal of the American Academy of Dermatology. 79(2). 245–251. 21 indexed citations
7.
Carney, Patricia A., Frederick A. Spencer, Lisa M. Reisch, et al.. (2018). Complexities of perceived and actual performance in pathology interpretation: A comparison of cutaneous melanocytic skin and breast interpretations. Journal of Cutaneous Pathology. 45(7). 478–490. 2 indexed citations
8.
Taylor, Laura A., Lisa M. Reisch, Joann G. Elmore, et al.. (2018). Influence of variability in assessment of Breslow thickness, mitotic rate and ulceration among US pathologists interpreting invasive melanoma, for the purpose of AJCC staging. Journal of Cutaneous Pathology. 45(8). 588–596. 7 indexed citations
9.
Taylor, Laura A., Ronnie M. Abraham, Emin Tahirović, et al.. (2017). High ALDH1 expression correlates with better prognosis in tumorigenic malignant melanoma. Modern Pathology. 30(5). 634–639. 10 indexed citations
10.
Zhao, Ge, Kachiu C. Lee, Gina P. Kwon, et al.. (2016). The self‐reported use of immunostains and cytogenetic testing in the diagnosis of melanoma by practicing U.S. pathologists of 10 selected states. Journal of Cutaneous Pathology. 43(6). 492–497. 9 indexed citations
11.
Newton‐Bishop, Julia, Samantha Beswick, Juliette A. Randerson‐Moor, et al.. (2009). Serum 25-Hydroxyvitamin D 3 Levels Are Associated With Breslow Thickness at Presentation and Survival From Melanoma. Journal of Clinical Oncology. 27(32). 5439–5444. 214 indexed citations
12.
Smalley, Keiran S.M., Mercedes Lioni, Maurizia Dalla Palma, et al.. (2008). Increased cyclin D1 expression can mediate BRAF inhibitor resistance in BRAF V600E–mutated melanomas. Molecular Cancer Therapeutics. 7(9). 2876–2883. 244 indexed citations
13.
Fargnoli, Maria Concetta, Ruth M. Pfeiffer, Shirley Tsang, et al.. (2008). MC1R Variants Increase Risk of Melanomas Harboring BRAF Mutations. Journal of Investigative Dermatology. 128(10). 2485–2490. 54 indexed citations
14.
Landi, Maria Teresa, Jürgen Bauer, Ruth M. Pfeiffer, et al.. (2006). MC1R Germline Variants Confer Risk for BRAF -Mutant Melanoma. Science. 313(5786). 521–522. 238 indexed citations
15.
Li, Jian, Patricia Van Belle, Ping Tsui, et al.. (2001). Isolation of the Melanoma-Associated Antigen p23 Using Antibody Phage Display. The Journal of Immunology. 166(1). 432–438. 15 indexed citations
16.
Lyle, Stephen, et al.. (1999). Cytokeratin 15 expression in trichoepitheliomas and a subset of basal cell carcinomas suggests they originate from hair follicle stem cells. Journal of Cutaneous Pathology. 26(3). 113–118. 97 indexed citations
17.
Belle, Patricia Van, David E. Elder, Haruhiko Maruyama, et al.. (1997). Combinatorial Antibodies Against Human Malignant Melanoma. Hybridoma. 16(1). 11–16. 24 indexed citations
18.
Murphy, Gëorge F. & David E. Elder. (1991). Non-melanocytic tumors of the skin. 53 indexed citations
19.
Elder, David E.. (1987). Pathobiology of malignant melanoma. KARGER eBooks. 8 indexed citations
20.
Herlyn, Meenhard, Jan Thurin, Gloria Balaban, et al.. (1985). Characteristics of cultured human melanocytes isolated from different stages of tumor progression.. PubMed. 45(11 Pt 2). 5670–6. 223 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Boris C. Bastian Breakdown of academic impact, for papers by Víctor G. Prieto Breakdown of academic impact, for papers by Timothy M. Johnson Breakdown of academic impact, for papers by Hensin Tsao Breakdown of academic impact, for papers by Wallace H. Clark Breakdown of academic impact, for papers by Alan N. Houghton Breakdown of academic impact, for papers by Allan Balmain Breakdown of academic impact, for papers by Kevin C. Gatter Breakdown of academic impact, for papers by Carola Berking Breakdown of academic impact, for papers by Robert L. Yauch
Rankless by CCL
2026